Collegium Pharmaceutical Inc’s recent filing unveils that its Director Fallon John A. unloaded Company’s shares for reported $1.65 million on Nov 12 ’25. In the deal valued at $47.21 per share,34,853 shares were sold. As a result of this transaction, Fallon John A. now holds 64,634 shares worth roughly $2.95 million.
Then, Fallon John A. bought 34,853 shares, generating $1,645,536 in total proceeds.
Before that, Tupper Colleen sold 30,000 shares. Collegium Pharmaceutical Inc shares valued at $1,215,753 were divested by the EVP & Chief Financial Officer at a price of $40.53 per share. As a result of the transaction, Tupper Colleen now holds 126,667 shares, worth roughly $5.78 million.
Needham upgraded its Collegium Pharmaceutical Inc [COLL] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late July from “a Neutral” to “a Buy”. Jefferies also remained covering COLL and has increased its forecast on June 07, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on May 10, 2024. It rated COLL as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of COLL
On Tuesday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 0.05% to $45.6. Over the last five days, the stock has gained 0.57%. Collegium Pharmaceutical Inc shares have risen nearly 49.95% since the year began. Nevertheless, the stocks have risen 59.16% over the past one year. While a 52-week high of $48.18 was reached on 11/13/25, a 52-week low of $23.23 was recorded on 04/10/25.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 45.23, which if violated will result in even more drops to 44.87. On the upside, there is a resistance level at 46.23. A further resistance level may holdings at 46.87.
How much short interest is there in Collegium Pharmaceutical Inc?
A steep rise in short interest was recorded in Collegium Pharmaceutical Inc stocks on 2025-11-14, growing by 0.45 million shares to a total of 5.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 5.23 million shares. There was a rise of 7.9%, which implies that there is a positive sentiment for the stock.
